MIRAMAR, Fla., Aug. 27, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NGIO) today announced that it has cancelled the investor conference call originally scheduled to be held, Thursday, August 27, 2020 at 9:30 am.
The conference call has been cancelled because the updates on the Ii-Key-SARS-CoV-2 vaccine, the potential deals with Malaysia and China, the planned meeting with the Canadian National Research Council, also the planned listing of NGIO on a national exchange were all discussed on today’s conference call with Generex shareholders.
Mr. Moscato said, “We are sorry to cancel this call at the last minute, but all of the topics we planned to cover on the call were covered in yesterday’s shareholders call. The audio transcript is on our website for review and the written transcript will be available on the company web site at www.generex.com in the coming days. Please listen to the audio transcript or read the written transcript to get the updates on NGIO and the Ii-Key-SARS-CoV-2 vaccine program. If you have further questions, you can email info@generex.com and we will get back to you.”
